GlassScriptPhysician profile
Janey L Chrisman
NPI 1700242088
$2,835.57
in general payments reported to CMS, 2019-2025
29 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.92 · 2022: $259 · 2023: $319 · 2024: $1,001 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,468.60 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $796.96 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $400.45 | 2023-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $288.89 | 2024-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.19 | 2021-2023 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Genzyme Corporation | $142.23 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $126.59 | 2022-2025 | Zerbaxa, Recarbrio, Winrevair |
| Amgen INC. | $121.72 | 2024-2025 | Tezspire |
| Baxter Healthcare | $88.44 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $85.28 | 2023 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $68.94 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Insmed, INC. | $66.57 | 2023-2025 | Arikayce |
| Viatris Specialty LLC | $57.95 | 2025 | Yupelri |
| Verona Pharma, INC. | $46.60 | 2025 | Ohtuvayre |
| Abbvie INC. | $45.30 | 2024-2025 | |
| United Therapeutics Corporation | $43.35 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38.08 | 2024 | Xarelto |
| Mallinckrodt Hospital Products INC. | $30.18 | 2022-2023 | Acthar |
| Alexion Pharmaceuticals, INC. | $29.78 | 2021-2022 | |
| Mylan Specialty L.P. | $29.09 | 2022 | |
| Aimmune Therapeutics, INC. | $21.49 | 2024 | |
| Vapotherm INC | $19.90 | 2022 | |
| Grifols USA, LLC | $19.56 | 2022 | |
| Ani Pharmaceuticals, INC. | $19.42 | 2024 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $17.90 | 2021 | |
| Philips North America LLC | $17.72 | 2025 | Vest Therapy Und |
| Shionogi INC | $17.28 | 2022 | |
| Phadia US INC. | $16.30 | 2025 | Immunocap |
| Takeda Pharmaceuticals U.S.A., INC. | $16.27 | 2024 | Glassia |
| Ambu INC. | $14.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janey Chrisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.